Keymed Biosciences (HKSE:02162) Short-Term Debt : HK$50.1 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Keymed Biosciences Short-Term Debt?

Keymed Biosciences's Short-Term Debt for the quarter that ended in Dec. 2023 was HK$50.1 Mil.

Keymed Biosciences's quarterly Short-Term Debt declined from Dec. 2022 (HK$68.3 Mil) to Jun. 2023 (HK$12.9 Mil) but then increased from Jun. 2023 (HK$12.9 Mil) to Dec. 2023 (HK$50.1 Mil).

Keymed Biosciences's annual Short-Term Debt increased from Dec. 2021 (HK$0.0 Mil) to Dec. 2022 (HK$68.3 Mil) but then declined from Dec. 2022 (HK$68.3 Mil) to Dec. 2023 (HK$50.1 Mil).

Keymed Biosciences Short-Term Debt Historical Data

The historical data trend for Keymed Biosciences's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Keymed Biosciences Short-Term Debt Chart

Keymed Biosciences Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

53.13

50.23

68.30

50.12

Keymed Biosciences Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Debt	Get a 7-Day Free Trial				-	117.22	68.30	12.86	50.12

Keymed Biosciences Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Keymed Biosciences Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Keymed Biosciences's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Keymed Biosciences (HKSE:02162) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Keymed Biosciences Inc (HKSE:02162) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

64Z:Germany

Address

No. 18 BioTown Middle Road, Building D2, Tianfu International BioTown, Chengdu, Sichuan, CHN, 610219

Website

https://www.keymedbio.com

Keymed Biosciences Inc is a biotechnology company with multiple clinical-stage assets. The company is focused on the in-house discovery and development of innovative biological therapies that address large underserved medical needs in the autoimmune and oncology therapeutic areas. The Group is engaged in biopharmaceutical research and development, which is regarded as a single reportable segment. Geographically, it operates in Hong Kong & Mainland China, out of which the majority is from Mainland China.

Executives

Chen Bo	2201 Interest of corporation controlled by you
Eagle Hero Management Limited	2101 Beneficial owner
Trident Trust Company (hk) Limited	2301 Trustee
Moonshot Holdings Limited	2101 Beneficial owner
Hh Kny Holdings Limited
Hillhouse Investment Management, Ltd.
Boyu Capital Group Holdings Ltd
Xyxy Holdings Ltd.
Tong Xiaomeng

Keymed Biosciences (HKSE:02162) Headlines

No Headlines